[HTML][HTML] EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - Elsevier
Background A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …

[PDF][PDF] EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - core.ac.uk
Background: A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …

[HTML][HTML] EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - jto.org
Background A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …

[引用][C] EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - cir.nii.ac.jp
EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients
with Advanced Non-small Cell Lung Cancer (NSCLC) | CiNii Research CiNii 国立情報学 …

EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi… - Journal of thoracic …, 2007 - pubmed.ncbi.nlm.nih.gov
Background A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …

[PDF][PDF] EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - scholar.archive.org
Background: A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …

[PDF][PDF] EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - academia.edu
Background: A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …

EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).

F Cappuzzo, C Ligorio, L Toschi, E Rossi… - Journal of Thoracic …, 2007 - europepmc.org
Background A critical point in designing clinical trials comparing chemotherapy with
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with non …